The role of weekly nanoparticle albumin bound paclitaxel monotherapy as second line or later treatment for advanced NSCLC in China

For patients with pretreated advanced non-small cell lung cancer (NSCLC), more effective treatments are unmet. We conducted a study to explore the optimal treatment schedule of nanoparticle albumin bound paclitaxel (Nab-PTX) as a second line or later treatment for advanced NSCLC patients in China. N...

Descripción completa

Detalles Bibliográficos
Autores principales: Xing, Puyuan, Zhu, Yixiang, Shan, Ling, Chen, Sipeng, Hao, Xuezhi, Li, Junling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675645/
https://www.ncbi.nlm.nih.gov/pubmed/29152093
http://dx.doi.org/10.18632/oncotarget.21103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675645/
https://www.ncbi.nlm.nih.gov/pubmed/29152093
http://dx.doi.org/10.18632/oncotarget.21103

Ejemplares similares